BioSante CEO hasn't given up on LibiGel, BioMedReports says
Yahoo/Fly on the Wall
BioSante Pharmaceuticals Reports Positive LibiGel Safety Data Review for Phase III Program
Pipeline Review
[video] The Next Big Thing In Biotech: Biosante
TheStreet.com

